Michael G. Hanna

Michael G Hanna (born 1963 in Leeds, England) is Director of the UCL Institute of Neurology, University College London and Professor in Clinical Neurology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London, and also Director of the Medical Research Council (MRC) Centre for Neuromuscular Disease.^{[2][3][4][5][6]}

Education

Hanna attended Lawnswood comprehensive state high school in Leeds and undertook undergraduate training in Medical Biochemistry and then Medicine at the University of Manchester graduating with honours in 1988.

Career and research

He undertook postgraduate medical and neurological training at the Newcastle upon Tyne University teaching Hospitals and at the John Radcliffe Hospital in Oxford and at the National Hospital for Neurology and Neurosurgery, Queen Square, London, London. He undertook neurological research training as an MRC Clinical Training Fellow ^[7] at the UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London.

Hanna was appointed Consultant Neurologist (Neurology) to the National Hospital for Neurology and Neurosurgery, Queen Square, London, University College Hospital, NHS FT in 1998 and promoted to University College London Professor of Clinical Neurology in 2006. He was Clinical Director of the National Hospital for Neurology and Neurosurgery from 2007-2012; the largest neurological disease hospital in the UK assessing over 130,000 patients per year.^[8] He commenced as Director of the UCL Institute of Neurology, Queen Square, London in 2012. The UCL Institute of Neurology is the largest neurological research institute in the UK with over 600 research staff and an annual turnover of £60m.^[9][10]

Through his research career he has secured external research grant funding exceeding £20m and has published over 275 peer reviewed full research articles and over 200 published science conference research abstracts. He is known internationally for his research and clinical expertise in neuromuscular diseases. He leads research groups investigating genetics, diseases mechanisms and potential therapies in human mitochondrial diseases, neurological channelopathies and inclusion body myositis. He has successfully translated his research into NHS England nationally commissioned highly specialised clinical services for patients with mitochondrial diseases and channelopathies.

Awards and achievements

Hanna established the MRC Centre for Translational Research in Neuromuscular Disease.^[11]

He was voted best clinical teacher by clinical medical students year 2000.^[12]

He has delivered a number of keynote lectures and memorial lectures worldwide including the UK, (Goulstonian Lectureship to the Royal College of Physicians in 2003 Goulstonian Lectures), and the prestigious Ian MacDonald Lecture.^[13][14]

He was elected a Guarantor of Brain in 2009,^[15] and a corresponding member of the American Neurology Association in 2010.^[16][17]

He is founding chairman of the successful British Myology Society; a registered charity dedicated to advancing education, clinical practice, trials and translational research in muscle diseases. Founded in 2008; chairman for 10 years, currently trustee.

In 2016 he was appointed chairman of the board of trustees of Muscular Dystrophy UK- the UK’s largest neuromuscular diseases charity which funds research, improves NHS services for patients and promotes independent living- charity turnover ~£7m

References